tiprankstipranks
Hoth Therapeutics (HOTH)
NASDAQ:HOTH
US Market
HOTH
Hoth Therapeutics
RESEARCH TOOLSreports

Hoth Therapeutics (HOTH) Income Statement

490 Followers

Hoth Therapeutics Income Statement

Last quarter (Q4 2025), Hoth Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Hoth Therapeutics's net income was $-2.69M. See Hoth Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ -66.83K$ 0.00
Operating Expenses
$ 11.11M$ 8.22M$ 7.69M$ 11.07M$ 14.10M
Depreciation and Amortization
$ 0.00$ 8.22M$ 7.69M$ 11.07M$ 0.00
EBITDA
$ -11.11M$ 27.13K$ -153.15K$ 0.00$ -14.10M
Operating Income
$ -11.11M$ -8.22M$ -7.69M$ -11.07M$ -14.10M
Other Income/Expenses
$ -1.36M$ 27.13K$ -153.15K$ -306.40K$ -212.26K
Pretax Income
$ -12.47M$ -8.19M$ -7.85M$ -11.37M$ -14.31M
Net Income
$ -12.47M$ -8.19M$ -7.85M$ -11.68M$ -14.31M
Per Share Metrics
Basic EPS
$ -0.90$ -1.28$ -2.30$ -9.75$ -16.03
Diluted EPS
$ -0.90$ -1.28$ -2.30$ -9.75$ -16.03
Weighted Average Shares Outstanding
 13.81M 6.38M 3.41M 1.20M 893.20K
Weighted Average Shares Outstanding (Diluted)
 13.81M 6.38M 3.41M 1.20M 893.20K
Currency in USD

Hoth Therapeutics Earnings and Revenue History